Alvotech Warrant
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic art… Read more
Alvotech Warrant (ALVOW) - Net Assets
Latest net assets as of September 2025: $-176.76 Million USD
Based on the latest financial reports, Alvotech Warrant (ALVOW) has net assets worth $-176.76 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.41 Billion) and total liabilities ($1.59 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-176.76 Million |
| % of Total Assets | -12.54% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Alvotech Warrant - Net Assets Trend (2020–2024)
This chart illustrates how Alvotech Warrant's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Alvotech Warrant (2020–2024)
The table below shows the annual net assets of Alvotech Warrant from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-412.77 Million | +55.73% |
| 2023-12-31 | $-932.49 Million | -65.21% |
| 2022-12-31 | $-564.42 Million | -316.20% |
| 2021-12-31 | $-135.61 Million | +84.36% |
| 2020-12-31 | $-867.24 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Alvotech Warrant's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 139867900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $2.83 Million | % |
| Other Comprehensive Income | $15.05 Million | % |
| Other Components | $2.01 Billion | % |
| Total Equity | $-412.77 Million | 100.00% |
Alvotech Warrant Competitors by Market Cap
The table below lists competitors of Alvotech Warrant ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Daesung Hi-Tech Co. Ltd.
KQ:129920
|
$35.03 Million |
|
Melcor Real Estate Investment Trust
TO:MR-UN
|
$35.04 Million |
|
ABITARE IN S.P.A.
F:1BN
|
$35.04 Million |
|
Chenghe Acquisition II Co.
NYSE MKT:CHEB
|
$35.04 Million |
|
Prestige Biologics Co. Ltd.
KQ:334970
|
$35.01 Million |
|
MAGELLANIC CLOUD LTD
NSE:MCLOUD
|
$35.00 Million |
|
Enertork Ltd
KQ:019990
|
$34.99 Million |
|
Bound and Beyond PCL
BK:BEYOND
|
$34.99 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Alvotech Warrant's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -932,493,000 to -412,771,000, a change of 519,722,000.
- Net loss of 231,864,000 reduced equity.
- New share issuances of 150,451,000 increased equity.
- Other comprehensive income decreased equity by 26,329,000.
- Other factors increased equity by 627,464,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-231.86 Million | -56.17% |
| Share Issuances | $150.45 Million | +36.45% |
| Other Comprehensive Income | $-26.33 Million | -6.38% |
| Other Changes | $627.46 Million | +152.01% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Alvotech Warrant's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $-27.75 | $0.33 | x |
| 2021-12-31 | $-4.34 | $0.33 | x |
| 2022-12-31 | $-2.85 | $0.33 | x |
| 2023-12-31 | $-4.10 | $0.33 | x |
| 2024-12-31 | $-1.54 | $0.33 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Alvotech Warrant utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -47.35%
- • Asset Turnover: 0.40x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | -255.26% | 0.14x | 0.00x | $-83.32 Million |
| 2021 | 0.00% | -276.04% | 0.06x | 0.00x | $-87.94 Million |
| 2022 | 0.00% | -618.55% | 0.10x | 0.00x | $-457.14 Million |
| 2023 | 0.00% | -603.42% | 0.10x | 0.00x | $-458.48 Million |
| 2024 | 0.00% | -47.35% | 0.40x | 0.00x | $-190.59 Million |
Industry Comparison
This section compares Alvotech Warrant's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Alvotech Warrant (ALVOW) | $-176.76 Million | 0.00% | N/A | $35.01 Million |
| Abcam plc (ABCZF) | $726.90 Million | -1.17% | 0.45x | $5.00 Billion |
| Able View Global Inc. Warrant (ABLVW) | $11.42 Million | 85.41% | 3.81x | $277.93K |
| Above Food Ingredients Inc. Warrants (ABVEW) | $199.86 Million | -2.89% | 0.00x | $6.25 Million |
| Adamas Trust, Inc. (ADAMG) | $2.43 Billion | 7.94% | 1.33x | $2.09 Billion |
| ADS-TEC ENERGY PLC Warrant (ADSEW) | $33.92 Million | -162.39% | 2.67x | $10.06 Million |
| Alliance Entertainment Holding Corporation Warrants (AENTW) | $52.92 Million | 10.13% | 4.23x | $2.29 Million |
| Forafric Global PLC Warrants (AFRIW) | $5.32 Million | -457.58% | 45.29x | $2.67 Million |
| Centurion Acquisition Corp. Warrant (ALFUW) | $282.84 Million | 1.97% | 0.05x | $4.81 Million |
| Alliance Trust PLC (ALITF) | $4.04 Billion | 10.04% | 0.29x | $112.87K |